BLCO
Bausch + Lomb·NYSE
--
--(--)
--
--(--)
BLCO fundamentals
Bausch + Lomb (BLCO) Revenue Breakdown: Q3 2025 Business & Regional Performance
Bausch + Lomb (BLCO) reported total revenue of 1.28B USD in Q3 2025, with its core business segment Pharmaceuticals contributing 21.86%. Regionally, United States and Puerto Rico remained the largest market, accounting for 50.92% of total revenue. Explore Bausch + Lomb's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Bausch + Lomb (BLCO) reported total revenue of 1.28B USD in Q3 2025, with its core business segment Pharmaceuticals contributing 21.86%. Regionally, United States and Puerto Rico remained the largest market, accounting for 50.92% of total revenue. Explore Bausch + Lomb's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Bausch + Lomb’s earnings call?What does Bausch + Lomb do and what are its main business segments?What is the revenue and EPS growth rate for Bausch + Lomb year over year?What were the key takeaways from Bausch + Lomb's earnings call?What factors drove the changes in Bausch + Lomb's revenue and profit?What is Bausch + Lomb's gross profit margin?What guidance did Bausch + Lomb's management provide for the next earnings period?What is Bausch + Lomb's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
